NMNH powder β-Nicotinamide Mononucleotide reduced form 95%

Shenzhen Hygieia Biotech Co., Ltd. (hereinafter referred to as "Hygieia") established its own Zymevolver ® strain construction and enzyme engineering evolution platform to carry out R&D, production and sales of pharmaceutical and dietary supplement raw materials, and currently we have a number of independent intellectual property rights.

Hygieia uses Artificial Intelligence(AI) to rapidly create new proteins, and combines new enzyme engineering technology to achieve more accurate, more efficient, and more economical development of protein drugs and industrial enzymes, achieving a technological breakthrough in the field of synthetic biology and protein engineering technology.

Hygieia has actively participated in the research projects of domestic and foreign research institutions, and has jointly promoted the clinical research of new products with Tsinghua University, Fudan University, Huazhong University of Science and Technology, Hong Kong University, etc., to provide more basic research data support for the new products.